The modulatory effects of MU and Kappa opioid agonists on 5-HT release from hippocampal and hypothalamic slices of euthermic and hibernating ground squirrels

Yan Cui, T. F. Lee, L. I. Kramarova, L. C.H. Wang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To elucidate the role of opioids in regulating hibernation, the modulatory effects of different opioids on 35 mM K+-stimulated [3H]-5-HT release from brain slices were examined in the Richardson's ground squirrels. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) inhibition of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. The inhibitory effect of DAGO was attenuated by either the opioid antagonist naloxone (10-6 M) or the voltage dependent sodium channel blocker tetrodotoxin (TTX, 10-6 M). The inhibitory effect of DAGO persisted in the hibernating squirrels; however, a ten fold higher concentration of DAGO (10-6-10-5 M) was required to elicit a significant inhibition. In contrast, κ agonist U50488 (10-5 M) exerted a significant enhancement of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. This enhancement was blocked by either the specific κ antagonist nor-binaltorphimine (10-6 M) or TTX (10-6 M). However, in the hibernating squirrels, the stimulatory effect of U50488 (10-5 M) on 5-HT release was absent. DAGO and U50488 had no modulatory effects on K+-stimulated 5-HT release from the hypothalamic slices of either the non-hibernating or hibernating squirrels. These results demonstrate that the modulatory effects of opioids on 5-HT release are receptor-specific and state-dependent, indicating the complex nature of the roles of different opioids in regulating hibernation.

Original languageEnglish (US)
Pages (from-to)1957-1965
Number of pages9
JournalLife Sciences
Volume53
Issue number26
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Serotonin Receptor Agonists
Sciuridae
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Opioid Analgesics
Serotonin
Hibernation
Sodium Channel Blockers
Narcotic Antagonists
Enkephalins
Serotonin Receptors
Tetrodotoxin
Naloxone
Brain
Electric potential

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The modulatory effects of MU and Kappa opioid agonists on 5-HT release from hippocampal and hypothalamic slices of euthermic and hibernating ground squirrels. / Cui, Yan; Lee, T. F.; Kramarova, L. I.; Wang, L. C.H.

In: Life Sciences, Vol. 53, No. 26, 01.01.1993, p. 1957-1965.

Research output: Contribution to journalArticle

@article{6513b49eb1f6459cbd5db53fd8003194,
title = "The modulatory effects of MU and Kappa opioid agonists on 5-HT release from hippocampal and hypothalamic slices of euthermic and hibernating ground squirrels",
abstract = "To elucidate the role of opioids in regulating hibernation, the modulatory effects of different opioids on 35 mM K+-stimulated [3H]-5-HT release from brain slices were examined in the Richardson's ground squirrels. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) inhibition of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. The inhibitory effect of DAGO was attenuated by either the opioid antagonist naloxone (10-6 M) or the voltage dependent sodium channel blocker tetrodotoxin (TTX, 10-6 M). The inhibitory effect of DAGO persisted in the hibernating squirrels; however, a ten fold higher concentration of DAGO (10-6-10-5 M) was required to elicit a significant inhibition. In contrast, κ agonist U50488 (10-5 M) exerted a significant enhancement of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. This enhancement was blocked by either the specific κ antagonist nor-binaltorphimine (10-6 M) or TTX (10-6 M). However, in the hibernating squirrels, the stimulatory effect of U50488 (10-5 M) on 5-HT release was absent. DAGO and U50488 had no modulatory effects on K+-stimulated 5-HT release from the hypothalamic slices of either the non-hibernating or hibernating squirrels. These results demonstrate that the modulatory effects of opioids on 5-HT release are receptor-specific and state-dependent, indicating the complex nature of the roles of different opioids in regulating hibernation.",
author = "Yan Cui and Lee, {T. F.} and Kramarova, {L. I.} and Wang, {L. C.H.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0024-3205(93)90017-W",
language = "English (US)",
volume = "53",
pages = "1957--1965",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "26",

}

TY - JOUR

T1 - The modulatory effects of MU and Kappa opioid agonists on 5-HT release from hippocampal and hypothalamic slices of euthermic and hibernating ground squirrels

AU - Cui, Yan

AU - Lee, T. F.

AU - Kramarova, L. I.

AU - Wang, L. C.H.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - To elucidate the role of opioids in regulating hibernation, the modulatory effects of different opioids on 35 mM K+-stimulated [3H]-5-HT release from brain slices were examined in the Richardson's ground squirrels. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) inhibition of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. The inhibitory effect of DAGO was attenuated by either the opioid antagonist naloxone (10-6 M) or the voltage dependent sodium channel blocker tetrodotoxin (TTX, 10-6 M). The inhibitory effect of DAGO persisted in the hibernating squirrels; however, a ten fold higher concentration of DAGO (10-6-10-5 M) was required to elicit a significant inhibition. In contrast, κ agonist U50488 (10-5 M) exerted a significant enhancement of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. This enhancement was blocked by either the specific κ antagonist nor-binaltorphimine (10-6 M) or TTX (10-6 M). However, in the hibernating squirrels, the stimulatory effect of U50488 (10-5 M) on 5-HT release was absent. DAGO and U50488 had no modulatory effects on K+-stimulated 5-HT release from the hypothalamic slices of either the non-hibernating or hibernating squirrels. These results demonstrate that the modulatory effects of opioids on 5-HT release are receptor-specific and state-dependent, indicating the complex nature of the roles of different opioids in regulating hibernation.

AB - To elucidate the role of opioids in regulating hibernation, the modulatory effects of different opioids on 35 mM K+-stimulated [3H]-5-HT release from brain slices were examined in the Richardson's ground squirrels. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) inhibition of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. The inhibitory effect of DAGO was attenuated by either the opioid antagonist naloxone (10-6 M) or the voltage dependent sodium channel blocker tetrodotoxin (TTX, 10-6 M). The inhibitory effect of DAGO persisted in the hibernating squirrels; however, a ten fold higher concentration of DAGO (10-6-10-5 M) was required to elicit a significant inhibition. In contrast, κ agonist U50488 (10-5 M) exerted a significant enhancement of K+-stimulated 5-HT release from hippocampal slices of the non-hibernating squirrels. This enhancement was blocked by either the specific κ antagonist nor-binaltorphimine (10-6 M) or TTX (10-6 M). However, in the hibernating squirrels, the stimulatory effect of U50488 (10-5 M) on 5-HT release was absent. DAGO and U50488 had no modulatory effects on K+-stimulated 5-HT release from the hypothalamic slices of either the non-hibernating or hibernating squirrels. These results demonstrate that the modulatory effects of opioids on 5-HT release are receptor-specific and state-dependent, indicating the complex nature of the roles of different opioids in regulating hibernation.

UR - http://www.scopus.com/inward/record.url?scp=0027500997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027500997&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(93)90017-W

DO - 10.1016/0024-3205(93)90017-W

M3 - Article

VL - 53

SP - 1957

EP - 1965

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 26

ER -